Biological assets: disclosure of public firms listed in the Ibovespa

This paper aims to examine the adoption of CPC 29 - biological assets - among companies listed at Ibovespa. It was established by the Brazilian Securities and Exchange Commission that as off 2012 enterprises would have to register its biological assets by fair value (biological assets were previously recorded by formation cost method), recognizing the impacts of the biological assets at the financial statements. To achieve the established purpose of the paper, it was performed a content analysis of the entities subjected to CPC 29 listed at Ibovespa. For that, we collected the 2010 quarterly and annual reports. As so, it was noticed that the main supersector, with 100% of the enterprises with biological assets is Cellulose & Paper. 1/3 of the companies from Basic Resources supersector (Oil & Gas sector) recognize biological assets, while in the supersector of Food & Beverage 3/5 of the entities disclosure biological assets. More else, five companies early adopted the rules at the quarterly financial reports and annual reports, but one didn't disclosure biological assets at the annual financial report.